DEXCOM, INC. Proceeds from Lines of Credit
DEXCOM, INC. (DXCM) reported Proceeds from Lines of Credit of $75.00 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-27.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromLinesOfCredit · last filed 2019-02-21
- DEXCOM, INC. proceeds from lines of credit for the quarter ending 2017-12-31 was $0.00.
- DEXCOM, INC. proceeds from lines of credit for the quarter ending 2017-09-30 was $0.00.
- DEXCOM, INC. proceeds from lines of credit for the quarter ending 2017-06-30 was $75.00M.
- DEXCOM, INC. proceeds from lines of credit for the quarter ending 2017-03-31 was $75.00M.
- DEXCOM, INC. proceeds from lines of credit for fiscal 2017 was $75.00M.
| Period end | Proceeds from Lines of Credit 1 month | Proceeds from Lines of Credit 3 month | Proceeds from Lines of Credit 6 month | Proceeds from Lines of Credit 9 month | Proceeds from Lines of Credit 12 month |
|---|---|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $0.00 derived: sum of 2 quarters · filed 2018-02-27 | $75.00M derived: sum of 3 quarters · filed 2018-08-01 | $75.00M 10-K · filed 2018-02-27 | |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | $75.00M derived: sum of 2 quarters · filed 2018-08-01 | $75.00M 10-Q · filed 2017-11-01 | ||
| 2017-06-30 | $75.00M 10-Q · filed 2018-08-01 | $75.00M 10-Q · filed 2017-08-01 | |||
| 2017-03-31 | $75.00M 10-K · filed 2019-02-21 | $75.00M 10-Q · filed 2018-05-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |